help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoheisel, G. B.
Right arrow Articles by Costabel, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoheisel, G. B.
Right arrow Articles by Costabel, U.

Am. J. Respir. Crit. Care Med., Vol 149, No. 2, Feb 1994, 460-463.

Bronchoalveolar lavage cytology and immunocytology in pulmonary tuberculosis

GB Hoheisel, L Tabak, H Teschler, F Erkan, C Kroegel and U Costabel
Department of Pneumology/Allergy, Ruhrlandklinik, Medical Faculty, Essen University, Germany.

Limited data on the cellular and immunocytologic characteristics of bronchoalveolar lavage (BAL) fluid in pulmonary tuberculosis have been reported. We therefore studied 40 patients with active disease. BAL fluid differential cell counts and lymphocyte subsets were determined. The findings were compared with data from 47 patients with active sarcoidosis and 30 healthy control subjects. The proportion of lymphocytes was increased in both diseases (p < 0.001 versus control subjects) but with no difference compared to one another. The CD4/CD8 ratio was normal in 33 of 40 patients with pulmonary tuberculosis in contrast to sarcoidosis, with an increased ratio in 33 of 47 patients. HLA-DR+ T lymphocytes were significantly increased in both pulmonary tuberculosis and sarcoidosis (p < 0.05 versus control group). The proportion of CD57+ lymphocytes was normal in all study groups. We conclude that pulmonary tuberculosis and sarcoidosis are characterized by an increased percentage of lymphocytes in BAL fluid with a similar proportion of activated T cells. In contrast to active sarcoidosis, in which an elevated CD4/CD8 ratio is characteristic, in the majority of pulmonary tuberculosis patients the CD4/CD8 ratio is within the normal range.


This article has been cited by other articles:


Home page
Eur Respir JHome page
C. Jafari, M. Ernst, A. Strassburg, U. Greinert, B. Kalsdorf, D. Kirsten, and C. Lange
Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot
Eur. Respir. J., February 1, 2008; 31(2): 261 - 265.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
B J L Burton, R A M Breen, G Janossy, J F Acheson, and M C I Lipman
Use of pulmonary interferon {gamma} responses to mycobacterial antigen to distinguish sarcoid associated optic neuropathy from tuberculosis
Br. J. Ophthalmol., June 1, 2006; 90(6): 802 - 803.
[Full Text] [PDF]


Home page
Eur Respir JHome page
S. Greco, A. Marruchella, M. Massari, and C. Saltini
Predictive value of BAL cellular analysis in differentiating pulmonary tuberculosis and sarcoidosis
Eur. Respir. J., August 1, 2005; 26(2): 360 - 362.
[Full Text] [PDF]


Home page
ThoraxHome page
R Golpe, A Mateos, N Kunichika, and H Kunichika
Rifampicin induced pneumonitis or bronchogenic spread of tuberculous empyema through a bronchopleural fistula?
Thorax, October 1, 2003; 58(10): 910 - 910.
[Full Text] [PDF]


Home page
ChestHome page
T. C. Y. Tsao, C.-H. Chen, J.-h. Hong, M.-J. Hsieh, K.-C. Tsao, and C.-H. Lee
Shifts of T4/T8 T Lymphocytes From BAL Fluid and Peripheral Blood by Clinical Grade in Patients With Pulmonary Tuberculosis
Chest, October 1, 2002; 122(4): 1285 - 1291.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. FUHRMAN, A. PARROT, M. WISLEZ, H. PRIGENT, V. BOUSSAUD, J.-F. BERNAUDIN, C. MAYAUD, and J. CADRANEL
Spectrum of CD4 to CD8 T-Cell Ratios in Lymphocytic Alveolitis Associated with Methotrexate-induced Pneumonitis
Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1186 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. Raju, C. F. Tung, D. Cheng, N. Yousefzadeh, R. Condos, W. N. Rom, and D. B. Tse
In Situ Activation of Helper T Cells in the Lung
Infect. Immun., August 1, 2001; 69(8): 4790 - 4798.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. GIOSUE, M. CASARINI, L. ALEMANNO, G. GALLUCCIO, P. MATTIA, G. PEDICELLI, L. REBEK, A. BISETTI, and F. AMEGLIO
Effects of Aerosolized Interferon-alpha in Patients with Pulmonary Tuberculosis
Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1156 - 1162.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
R. J. Harbeck

Clin. Vaccine Immunol., May 1, 1998; 5(3): 271 - 277.
[Full Text]


Home page
Infect. Immun.Home page
Y. Lin, M. Zhang, and P. F. Barnes
Chemokine Production by a Human Alveolar Epithelial Cell Line in Response to Mycobacterium tuberculosis
Infect. Immun., March 1, 1998; 66(3): 1121 - 1126.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. CONDOS, W. N. ROM, Y. M. LIU, and N. W. SCHLUGER
Local Immune Responses Correlate with Presentation and Outcome in Tuberculosis
Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 729 - 735.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1994 American Thoracic Society